Medicure Inc.

Medicure Inc.

MCUJF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$27.5M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medicure Inc.Medicure Inc.-5.2--72%0.90.1
$2.26

Current Fair Value

16% downside

Overvalued by 16% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$27.50 Million
Enterprise Value$27.27 Million
Earnings per Share$-0.68
Beta1.04
Outstanding Shares10,199,999

Return

Return on Equity-72.37%ROE
Return on Assets-35.12%
Return on Invested Capital-68.03%

Valuation & Multiples

P/E Ratio-5.22P/E Ratio
PEG99.81PEG
Price to Sales0.9Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.86
Enterprise Value to EBIT-3.78
Enterprise Value to Net Income-4
Total Debt to Enterprise0.03
Debt to Equity0.08Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 19, 2026
EPS
-$0.09
Est. -$0.02
Revenue
$5.39 M
Est. $5.08 M

Next Earnings Call

Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Medicure Inc.

23 employees
CEO: Albert David Friesen

Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key off...

Questions & Answers